Fieldpoint Private Securities LLC purchased a new position in Cerner Co. (NASDAQ:CERN) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 7,835 shares of the company’s stock, valued at approximately $559,000.
Other large investors have also modified their holdings of the company. ETF Managers Group LLC acquired a new stake in Cerner in the 2nd quarter worth about $157,000. Advisory Services Network LLC raised its holdings in shares of Cerner by 4.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,648 shares of the company’s stock worth $110,000 after purchasing an additional 70 shares during the period. Fuller & Thaler Asset Management Inc. purchased a new position in shares of Cerner in the 3rd quarter worth about $121,000. Acrospire Investment Management LLC raised its holdings in shares of Cerner by 100.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,800 shares of the company’s stock worth $120,000 after purchasing an additional 900 shares during the period. Finally, Pacad Investment Ltd. purchased a new position in shares of Cerner in the 2nd quarter worth about $130,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cerner Co. (NASDAQ CERN) opened at $69.66 on Thursday. The company has a market capitalization of $23,160.00, a PE ratio of 31.03, a P/E/G ratio of 2.26 and a beta of 0.94. The company has a current ratio of 2.77, a quick ratio of 2.75 and a debt-to-equity ratio of 0.11. Cerner Co. has a twelve month low of $47.09 and a twelve month high of $73.86.
Cerner (NASDAQ:CERN) last announced its earnings results on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing the consensus estimate of $0.62 by ($0.01). The company had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Cerner had a net margin of 13.37% and a return on equity of 18.03%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.59 earnings per share. research analysts predict that Cerner Co. will post 2.25 earnings per share for the current year.
In other Cerner news, Chairman Clifford W. Illig sold 4,000 shares of Cerner stock in a transaction that occurred on Tuesday, November 7th. The stock was sold at an average price of $65.96, for a total transaction of $263,840.00. Following the sale, the chairman now directly owns 1,229,719 shares in the company, valued at approximately $81,112,265.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Clifford W. Illig sold 530,000 shares of Cerner stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $65.54, for a total value of $34,736,200.00. Following the sale, the chairman now owns 1,229,719 shares in the company, valued at $80,595,783.26. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 788,000 shares of company stock worth $52,190,800. Company insiders own 13.11% of the company’s stock.
A number of equities analysts have recently commented on the company. Jefferies Group set a $79.00 price objective on Cerner and gave the stock a “buy” rating in a report on Friday, October 13th. SunTrust Banks restated a “buy” rating and issued a $75.00 price objective on shares of Cerner in a report on Monday, October 30th. Royal Bank of Canada assumed coverage on Cerner in a report on Tuesday, September 19th. They issued a “top pick” rating and a $84.00 price objective on the stock. KeyCorp restated a “buy” rating and issued a $76.00 price objective on shares of Cerner in a report on Friday, September 22nd. Finally, Robert W. Baird upgraded Cerner from a “neutral” rating to an “outperform” rating and raised their price objective for the stock from $67.00 to $76.00 in a report on Tuesday, October 31st. One investment analyst has rated the stock with a sell rating, fourteen have given a hold rating and nine have given a buy rating to the stock. Cerner has an average rating of “Hold” and a consensus target price of $69.50.
COPYRIGHT VIOLATION WARNING: This article was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://ledgergazette.com/2017/12/14/fieldpoint-private-securities-llc-takes-position-in-cerner-co-cern.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.